Picture Demy-Colton BioFuture 2024 NYC Reimagine Healthcare 650x100px
Organisation › Details

Tissium S.A.

TISSIUM is a privately-owned medtech company based in Paris, France and Boston, USA that is dedicated to the development and commercialization of a unique biopolymer platform to address multiple unmet clinical needs, including atraumatic tissue repair and reconstruction. TISSIUM is developing a portfolio of solutions that leverage its proprietary family of fully biosynthetic, biomorphic and programmable polymers, which are the foundation of the company’s technology platform. Currently, the Company has a pipeline of seven products across three verticals, including nerve repair, hernia and cardiovascular. Each product is designed to enhance the tissue reconstruction process in a unique way. The company also develops delivery and activation devices for enhanced performance and usability of its products. TISSIUM’s technology is based on world-class research and intellectual property from the laboratories of Professor Robert Langer (MIT) and Professor Jeffrey M. Karp (Brigham and Women’s Hospital), who co-founded the company in 2013. *


Period Start 2019-05-14 renamed
  Group Tissium (Group)
  Predecessor Gecko Biomedical (FR)
Products Industry tissues
  Industry 2 polymers
Person Person Bancel, Christophe (Gecko Biomedical 201603 CEO + Co-Founder)
Region Region Paris
  Country France
  Street 74 rue du Faubourg Saint-Antoine
  City 75012 Paris
  Tel +33-1-7621-7220
    Address record changed: 2024-01-05
Basic data Employees n. a.
    * Document for »About Section«: Tissium S.A.. (8/31/21). "Press Release: Tissium Raises €50M in Series C Financing to Propel Its Platform to Commercial Stage". Paris.
Record changed: 2024-02-12


Picture EBD Group BIO-Europe 2024 Stockholm BEU24 650x200px

More documents for Tissium (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture EBD Group BIO-Europe 2024 Stockholm BEU24 650x300px

» top